Activation of p53 for the treatment of cancer.
Chen
Jiezhong
J
University of Wollongong, New South Wales, Australia. jiezhong@uow.edu.au
Huang
Xu-Feng
XF
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis; D002945:Cisplatin / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010766:Phosphorylation / Q000187:drug effects; D011687:Purines / Q000627:therapeutic use; D000077546:Roscovitine; D016159:Tumor Suppressor Protein p53 / Q000819:agonists* / Q000378:metabolism
D000970:Antineoplastic Agents; D011687:Purines; D016159:Tumor Suppressor Protein p53; D000077546:Roscovitine; D002945:Cisplatin